Literature DB >> 15704852

Enhancement of dissolution rate of valdecoxib using solid dispersions with polyethylene glycol 4000.

Chengsheng Liu1, Chenguang Liu, Kashappa Goud H Desai.   

Abstract

The aim of the present study was to enhance the dissolution rate of valdecoxib using its solid dispersions (SDs) with polyethylene glycol (PEG) 4000. The phase solubility behavior of valdecoxib in the presence of various concentrations of PEG 4000 in water was obtained at 37 degrees C. The solubility of valdecoxib increased with increasing amount of PEG 4000 in water. Gibbs free energy (deltaG(zero)tr) values were all negative, indicating the spontaneous nature of valdecoxib solubilization, and they decreased with increase in the PEG 4000 concentration, demonstrating that the reaction conditions became more favorable as the concentration of PEG 4000 increased. The SDs of valdecoxib with PEG 4000 were prepared at 1:1, 1:2, 1:5, and 1:10 (valdecoxib: PEG 4000) ratio by melting method. Evaluation of the properties of the SDs was performed by using dissolution, Fourier-transform infrared (FTIR) spectroscopy, differential scanning calorimetry (DSC), X-ray diffraction (XRD), and scanning electron microscopy (SEM) studies. The SDs of valdecoxib with PEG 4000 exhibited enhanced dissolution rate of valdecoxib, and the rate increased with increasing concentration of PEG 4000 in SDs. Mean dissolution time (MDT) of valdecoxib decreased significantly after preparation of SDs and physical mixture with PEG 4000. The FTIR spectroscopic studies showed the stability of valdecoxib and absence of well-defined valdecoxib-PEG 4000 interaction. The DSC and XRD studies indicated the amorphous state of valdecoxib in SDs of valdecoxib with PEG 4000. The SEM pictures showed the formation of effective SDs of valdecoxib with PEG 4000, since well-defined changes in the surface nature of valdecoxib, SDs, and physical mixture were observed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15704852     DOI: 10.1081/ddc-43918

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  8 in total

1.  Physico-chemical characterization and in vitro dissolution assessment of clonazepam-cyclodextrins inclusion compounds.

Authors:  Rakesh Patel; Nirav Purohit
Journal:  AAPS PharmSciTech       Date:  2009-10-29       Impact factor: 3.246

2.  Formulation Development of Spherical Crystal Agglomerates of Itraconazole for Preparation of Directly Compressible Tablets with Enhanced Bioavailability.

Authors:  Janki Fadke; Jagruti Desai; Hetal Thakkar
Journal:  AAPS PharmSciTech       Date:  2015-05-20       Impact factor: 3.246

3.  Enhancement of dissolution rate of gliclazide using solid dispersions with polyethylene glycol 6000.

Authors:  S Biswal; J Sahoo; P N Murthy; R P Giradkar; J G Avari
Journal:  AAPS PharmSciTech       Date:  2008-05-06       Impact factor: 3.246

4.  Process optimization and characterization of poloxamer solid dispersions of a poorly water-soluble drug.

Authors:  Tejal J Shah; Avani F Amin; Jolly R Parikh; Rajesh H Parikh
Journal:  AAPS PharmSciTech       Date:  2007-04-13       Impact factor: 3.246

5.  Physiochemical Characterization and Release Rate Studies of SolidDispersions of Ketoconazole with Pluronic F127 and PVP K-30.

Authors:  Pankaj Kumar; Chander Mohan; Mara Kanamsrinivasan Uma Shankar; Monica Gulati
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

6.  Dissolution enhancement of efavirenz by solid dispersion and PEGylation techniques.

Authors:  B Bindu Madhavi; B Kusum; Ch Krishna Chatanya; M Naga Madhu; V Sri Harsha; David Banji
Journal:  Int J Pharm Investig       Date:  2011-01

7.  In vitro dissolution study of atorvastatin binary solid dispersion.

Authors:  Rahat Jahan; Md Saiful Islam; Ahmad Tanwir; Jakir Ahmed Chowdhury
Journal:  J Adv Pharm Technol Res       Date:  2013-01

8.  Formulation and evaluation of fixed-dose combination of bilayer gastroretentive matrix tablet containing atorvastatin as fast-release and atenolol as sustained-release.

Authors:  Sanjay Dey; Sankha Chattopadhyay; Bhaskar Mazumder
Journal:  Biomed Res Int       Date:  2014-01-02       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.